X-15331315-T-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_002641.4(PIGA):āc.616A>Gā(p.Ile206Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000664 in 1,204,690 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002641.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGA | NM_002641.4 | c.616A>G | p.Ile206Val | missense_variant | 2/6 | ENST00000333590.6 | NP_002632.1 | |
PIGA | NM_020473.3 | c.13+4186A>G | intron_variant | NP_065206.3 | ||||
PIGA | NR_033835.1 | n.457+275A>G | intron_variant | |||||
PIGA | NR_033836.1 | n.173+559A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGA | ENST00000333590.6 | c.616A>G | p.Ile206Val | missense_variant | 2/6 | 1 | NM_002641.4 | ENSP00000369820.3 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112258Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34398
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183476Hom.: 0 AF XY: 0.0000294 AC XY: 2AN XY: 67920
GnomAD4 exome AF: 0.00000458 AC: 5AN: 1092378Hom.: 0 Cov.: 28 AF XY: 0.00000279 AC XY: 1AN XY: 357884
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112312Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34462
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2016 | The p.I206V variant (also known as c.616A>G), located in coding exon 1 of the PIGA gene, results from an A to G substitution at nucleotide position 616. The isoleucine at codon 206 is replaced by valine, an amino acid with highly similar properties. Another variant at the same amino acid position (p.I206F) has been reported in a patient diagnosed with West syndrome with hypomyelination (Kato M et al. Neurology, 2014 May;82:1587-96). The p.I206V variant was previously reported in the SNPDatabase as rs201119959. Based on data from the 1000 Genomes Project, the G allele has an overall frequency of approximately 0% (0/503) total male alleles studied. In the NHLBI Exome Sequencing Project (ESP), this variant was not observed in 6503 samples with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2017 | A variant of uncertain significance has been identified in the PIGA gene. The I206V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. A different missense substitution at the same residue (I206F) has been previously reported as a maternally inherited variant in a male with West syndrome (Kato et al. 2014). The I206V variant is observed in 1/9319 (0.01%) alleles from individuals of Latino background, (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a position that is conserved across species. However, the I206V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Multiple congenital anomalies-hypotonia-seizures syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 03, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at